These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19345310)

  • 1. Detection of myocardial dysfunction during cancer chemotherapy with tissue Doppler imaging: a canary in the coal mine?
    Hoit BD
    J Am Soc Echocardiogr; 2009 Apr; 22(4):425-6. PubMed ID: 19345310
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.
    Jassal DS; Han SY; Hans C; Sharma A; Fang T; Ahmadie R; Lytwyn M; Walker JR; Bhalla RS; Czarnecki A; Moussa T; Singal PK
    J Am Soc Echocardiogr; 2009 Apr; 22(4):418-24. PubMed ID: 19269133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.
    Hare JL; Brown JK; Leano R; Jenkins C; Woodward N; Marwick TH
    Am Heart J; 2009 Aug; 158(2):294-301. PubMed ID: 19619708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
    Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
    Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction.
    Di Lisi D; Bonura F; Macaione F; Peritore A; Meschisi M; Cuttitta F; Novo G; D'Alessandro N; Novo S
    Anticancer Drugs; 2011 Jun; 22(5):468-72. PubMed ID: 21301318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough.
    Eidem BW
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1290-2. PubMed ID: 19041570
    [No Abstract]   [Full Text] [Related]  

  • 8. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of trastuzumab in clinical practice.
    McArthur HL; Chia S
    N Engl J Med; 2007 Jul; 357(1):94-5. PubMed ID: 17611218
    [No Abstract]   [Full Text] [Related]  

  • 10. Can modern echocardiographic techniques predict drug-induced cardiotoxicity?
    Edvardsen T
    J Am Coll Cardiol; 2011 May; 57(22):2271-2. PubMed ID: 21616288
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.
    Negishi K; Negishi T; Haluska BA; Hare JL; Plana JC; Marwick TH
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):324-31. PubMed ID: 24057661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between clinical risk factors and left ventricular function in patients with breast cancer following chemotherapy.
    Yamashita K; Tanaka H; Hatazawa K; Tanaka Y; Sumimoto K; Shono A; Suzuki M; Yokota S; Suto M; Mukai J; Takada H; Matsumoto K; Minami H; Hirata KI
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):197-205. PubMed ID: 32860123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.
    Jurcut R; Wildiers H; Ganame J; D'hooge J; De Backer J; Denys H; Paridaens R; Rademakers F; Voigt JU
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1283-9. PubMed ID: 19041569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
    Andreopoulou E; Gaiotti D; Kim E; Volm M; Oratz R; Freedberg R; Downey A; Vogel CL; Chia S; Muggia F
    Clin Breast Cancer; 2007 Aug; 7(9):690-6. PubMed ID: 17919349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.
    Tan-Chiu E; Yothers G; Romond E; Geyer CE; Ewer M; Keefe D; Shannon RP; Swain SM; Brown A; Fehrenbacher L; Vogel VG; Seay TE; Rastogi P; Mamounas EP; Wolmark N; Bryant J
    J Clin Oncol; 2005 Nov; 23(31):7811-9. PubMed ID: 16258083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab-induced cardiotoxicity: the role of two-dimensional myocardial strain imaging in diagnosis and management.
    Stoodley P; Tanous D; Richards D; Meikle S; Clarke J; Hui R; Thomas L
    Echocardiography; 2012 Jul; 29(6):E137-40. PubMed ID: 22381030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.
    Ewer MS; Vooletich MT; Durand JB; Woods ML; Davis JR; Valero V; Lenihan DJ
    J Clin Oncol; 2005 Nov; 23(31):7820-6. PubMed ID: 16258084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab for early breast cancer.
    Thorat M
    Lancet; 2006 Jan; 367(9505):108. PubMed ID: 16413867
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
    Chia S; Clemons M; Martin LA; Rodgers A; Gelmon K; Pond GR; Panasci L
    J Clin Oncol; 2006 Jun; 24(18):2773-8. PubMed ID: 16682726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial function in patients with breast cancer after therapy with anthracyclines and chest irradiation.
    Radulescu D; Pripon S; Parv A; Duncea C; Ciuleanu TE; Radulescu LI
    J BUON; 2007; 12(3):349-52. PubMed ID: 17918288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.